大幸薬品の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/07/21 | 1,002 | 1,020 | 1,000 | 1,015 | +28 | +2.8% | 301,800 |
2021/07/20 | 985 | 999 | 982 | 987 | -7 | -0.7% | 137,600 |
2021/07/19 | 985 | 1,000 | 980 | 994 | +4 | +0.4% | 142,100 |
2021/07/16 | 982 | 996 | 971 | 990 | +6 | +0.6% | 138,600 |
2021/07/15 | 1,008 | 1,012 | 978 | 984 | -24 | -2.4% | 277,500 |
2021/07/14 | 989 | 1,015 | 989 | 1,008 | +30 | +3.1% | 365,500 |
2021/07/13 | 970 | 985 | 967 | 978 | +13 | +1.3% | 173,000 |
2021/07/12 | 960 | 972 | 957 | 965 | +14 | +1.5% | 204,000 |
2021/07/09 | 950 | 954 | 927 | 951 | -4 | -0.4% | 448,000 |
2021/07/08 | 976 | 985 | 955 | 955 | -25 | -2.6% | 403,600 |
2021/07/07 | 988 | 994 | 976 | 980 | -13 | -1.3% | 315,300 |
2021/07/06 | 996 | 1,001 | 983 | 993 | -3 | -0.3% | 298,000 |
2021/07/05 | 1,001 | 1,002 | 990 | 996 | -6 | -0.6% | 209,000 |
2021/07/02 | 1,003 | 1,006 | 998 | 1,002 | -4 | -0.4% | 252,400 |
2021/07/01 | 1,018 | 1,020 | 1,003 | 1,006 | -12 | -1.2% | 180,200 |
2021/06/30 | 1,040 | 1,042 | 1,011 | 1,018 | -12 | -1.2% | 208,900 |
2021/06/29 | 1,027 | 1,040 | 1,023 | 1,030 | +3 | +0.3% | 133,800 |
2021/06/28 | 1,042 | 1,044 | 1,020 | 1,027 | -12 | -1.2% | 297,000 |
2021/06/25 | 1,049 | 1,049 | 1,036 | 1,039 | -6 | -0.6% | 79,900 |
2021/06/24 | 1,039 | 1,046 | 1,031 | 1,045 | +7 | +0.7% | 125,500 |
2021/06/23 | 1,045 | 1,053 | 1,031 | 1,038 | -11 | -1% | 186,600 |
2021/06/22 | 1,051 | 1,058 | 1,044 | 1,049 | -1 | -0.1% | 174,700 |
2021/06/21 | 1,028 | 1,056 | 1,028 | 1,050 | +4 | +0.4% | 274,100 |
2021/06/18 | 1,055 | 1,065 | 1,042 | 1,046 | -7 | -0.7% | 200,300 |
2021/06/17 | 1,040 | 1,055 | 1,035 | 1,053 | +15 | +1.4% | 225,700 |
2021/06/16 | 1,054 | 1,054 | 1,031 | 1,038 | -19 | -1.8% | 371,000 |
2021/06/15 | 1,060 | 1,063 | 1,052 | 1,057 | -3 | -0.3% | 113,100 |
2021/06/14 | 1,071 | 1,072 | 1,052 | 1,060 | -13 | -1.2% | 231,800 |
2021/06/11 | 1,073 | 1,086 | 1,066 | 1,073 | +7 | +0.7% | 184,100 |
2021/06/10 | 1,070 | 1,078 | 1,060 | 1,066 | -6 | -0.6% | 261,300 |
2021/06/09 | 1,069 | 1,082 | 1,058 | 1,072 | +4 | +0.4% | 194,300 |
2021/06/08 | 1,069 | 1,074 | 1,054 | 1,068 | +10 | +0.9% | 246,200 |
2021/06/07 | 1,051 | 1,063 | 1,046 | 1,058 | +15 | +1.4% | 203,600 |
2021/06/04 | 1,049 | 1,053 | 1,033 | 1,043 | -5 | -0.5% | 148,700 |
2021/06/03 | 1,034 | 1,052 | 1,031 | 1,048 | +19 | +1.8% | 215,000 |
2021/06/02 | 1,025 | 1,035 | 1,017 | 1,029 | -8 | -0.8% | 148,700 |
2021/06/01 | 1,053 | 1,054 | 1,023 | 1,037 | -16 | -1.5% | 312,700 |
2021/05/31 | 1,078 | 1,078 | 1,050 | 1,053 | -13 | -1.2% | 209,900 |
2021/05/28 | 1,077 | 1,082 | 1,060 | 1,066 | -6 | -0.6% | 242,200 |
2021/05/27 | 1,077 | 1,083 | 1,060 | 1,072 | -15 | -1.4% | 334,000 |
2021/05/26 | 1,094 | 1,099 | 1,078 | 1,087 | -8 | -0.7% | 207,000 |
2021/05/25 | 1,095 | 1,105 | 1,086 | 1,095 | -3 | -0.3% | 261,400 |
2021/05/24 | 1,090 | 1,100 | 1,069 | 1,098 | +12 | +1.1% | 327,800 |
2021/05/21 | 1,074 | 1,090 | 1,067 | 1,086 | +22 | +2.1% | 218,500 |
2021/05/20 | 1,050 | 1,075 | 1,050 | 1,064 | +2 | +0.2% | 343,200 |
2021/05/19 | 1,078 | 1,082 | 1,052 | 1,062 | -25 | -2.3% | 419,600 |
2021/05/18 | 1,097 | 1,105 | 1,084 | 1,087 | -20 | -1.8% | 329,800 |
2021/05/17 | 1,092 | 1,110 | 1,079 | 1,107 | +2 | +0.2% | 325,800 |
2021/05/14 | 1,059 | 1,129 | 1,059 | 1,105 | +50 | +4.7% | 486,500 |
2021/05/13 | 1,040 | 1,068 | 1,022 | 1,055 | +10 | +1% | 380,900 |
1001~
1050
件表示中 / 4021件
類似銘柄と比較する
現在ご覧いただいている「大幸薬品」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
大幸薬品 | 31,800円 | +0.1% | -70.9% | 0.00% | 35.49倍 | 2.01倍 |
|
止瀉薬「正露丸」で有名な大衆薬中堅。オーナー経営色。感染管理「クレベリン」事業は再構築中 |
ステムリム | 31,500円 | - | - | 0.00% | - | 2.90倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
オンコリス | 71,200円 | +3771.0% | - | 0.00% | - | 12.41倍 |
|
腫瘍溶解ウイルス技術使うがん治療薬柱に感染症薬も開発。導出先が神経疾患薬を米国治験中 |
ステラファーマ | 40,800円 | +4.8% | - | 0.00% | - | 4.33倍 |
|
ステラケミファ系、持分会社に。がん放射線治療用ホウ素医薬品が柱。適応拡大・海外展開注力 |
ラクオリア | 54,000円 | +25.1% | - | 0.00% | - | 2.11倍 |
|
ファイザー旧国内研究所が前身。導出消化器薬の海外売上が拡大、収益柱に。低分子創薬に強い |
市場注目の銘柄
チャート関連のコラム